Home/Filings/4/0001114220-18-000039
4//SEC Filing

Carberry Christine A. 4

Accession 0001114220-18-000039

CIK 0001114220other

Filed

Apr 19, 8:00 PM ET

Accepted

Apr 20, 4:11 PM ET

Size

5.1 KB

Accession

0001114220-18-000039

Insider Transaction Report

Form 4
Period: 2018-04-18
Carberry Christine A.
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2018-04-18$4.83/sh2,026$9,786115,176 total
Footnotes (2)
  • [F1]Sale of a total of 2,026 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,084 shares of restricted stock on April 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  • [F2]Includes 90,832 shares of restricted stock.

Issuer

KERYX BIOPHARMACEUTICALS INC

CIK 0001114220

Entity typeother

Related Parties

1
  • filerCIK 0001694459

Filing Metadata

Form type
4
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:11 PM ET
Size
5.1 KB